---
title: "Abiraterone acetate - Malignant tumor of prostate - 4"
sidebar: mydoc_sidebar
permalink: db05812-mesh-d011471-4.html
toc: false 
---


Path ID: `DB05812_MESH_D011471_4`
{% include image.html url="images/db05812-mesh-d011471-4.png" file="db05812-mesh-d011471-4.png" alt="db05812-mesh-d011471-4" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| DB:DB05812 | abiraterone acetate | Drug |
| UniProt:P10275 | Androgen receptor | Protein |
| GO:0060769 | positive regulation of epithelial cell proliferation involved in prostate gland development | BiologicalProcess |
| MESH:D011471 | Malignant tumor of prostate | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Abiraterone Acetate | DECREASES ACTIVITY OF | Androgen Receptor |
| Androgen Receptor | POSITIVELY REGULATES | Positive Regulation Of Epithelial Cell Proliferation Involved In Prostate Gland Development |
| Positive Regulation Of Epithelial Cell Proliferation Involved In Prostate Gland Development | POSITIVELY CORRELATED WITH | Malignant Tumor Of Prostate |
|---------|-----------|---------|

Comment: In addition to inhibiting UniProt:P05093 (the main target according to [https://go.drugbank.com/drugs/DB05812#mechanism-of-action),](https://go.drugbank.com/drugs/DB05812#mechanism-of-action),) abiraterone also acts as a partial antagonist of the androgen receptor (UniProt:P10275)

Reference: 
  - [https://en.wikipedia.org/wiki/Abiraterone_acetate#Pharmacology](https://en.wikipedia.org/wiki/Abiraterone_acetate#Pharmacology)
  - [https://en.wikipedia.org/wiki/Androgen_receptor#Mechanism_of_action](https://en.wikipedia.org/wiki/Androgen_receptor#Mechanism_of_action)
  - [https://en.wikipedia.org/wiki/Androgen_deprivation_therapy#Methods_based_on_drugs](https://en.wikipedia.org/wiki/Androgen_deprivation_therapy#Methods_based_on_drugs)
  - [https://www.kegg.jp/entry/D09701](https://www.kegg.jp/entry/D09701)

Reference: 
  - [https://en.wikipedia.org/wiki/Abiraterone_acetate#Pharmacology](https://en.wikipedia.org/wiki/Abiraterone_acetate#Pharmacology)
  - [https://en.wikipedia.org/wiki/Androgen_receptor#Mechanism_of_action](https://en.wikipedia.org/wiki/Androgen_receptor#Mechanism_of_action)
  - [https://en.wikipedia.org/wiki/Androgen_deprivation_therapy#Methods_based_on_drugs](https://en.wikipedia.org/wiki/Androgen_deprivation_therapy#Methods_based_on_drugs)
  - [https://www.kegg.jp/entry/D09701](https://www.kegg.jp/entry/D09701)

Reference: 
  - [https://en.wikipedia.org/wiki/Abiraterone_acetate#Pharmacology](https://en.wikipedia.org/wiki/Abiraterone_acetate#Pharmacology)
  - [https://en.wikipedia.org/wiki/Androgen_receptor#Mechanism_of_action](https://en.wikipedia.org/wiki/Androgen_receptor#Mechanism_of_action)
  - [https://en.wikipedia.org/wiki/Androgen_deprivation_therapy#Methods_based_on_drugs](https://en.wikipedia.org/wiki/Androgen_deprivation_therapy#Methods_based_on_drugs)
  - [https://www.kegg.jp/entry/D09701](https://www.kegg.jp/entry/D09701)

Reference: 
  - [https://en.wikipedia.org/wiki/Abiraterone_acetate#Pharmacology](https://en.wikipedia.org/wiki/Abiraterone_acetate#Pharmacology)
  - [https://en.wikipedia.org/wiki/Androgen_receptor#Mechanism_of_action](https://en.wikipedia.org/wiki/Androgen_receptor#Mechanism_of_action)
  - [https://en.wikipedia.org/wiki/Androgen_deprivation_therapy#Methods_based_on_drugs](https://en.wikipedia.org/wiki/Androgen_deprivation_therapy#Methods_based_on_drugs)
  - [https://www.kegg.jp/entry/D09701](https://www.kegg.jp/entry/D09701)
